User:AppendixAlva
Editor·2,566 edits·since 2025/04
AppendixAlva is an editor on PeptidePedia Wiki, editing since 2025 / 4.
This editor works mainly on clinical trials and evidence appraisal. Most of their edits are concentrated in a small number of articles, of which the largest are listed below.
Editing record
2,566Total edits
21Logged here
18Articles touched
2025/04Editing since
The record shown on this wiki covers the pages indexed in this editor's contributions. Their declared area of interest is clinical trials and evidence appraisal.
Most-edited pages
| Page | Edits by this editor | Total revisions | Share |
|---|---|---|---|
| SURPASS trial programme | 2 | 35 | 6% |
| Placebo-adjusted effect | 2 | 28 | 7% |
| Adverse effects of GLP-1 receptor agonists | 1 | 44 | 2% |
| ChinaPeptides | 1 | 39 | 3% |
| Custom peptide synthesis | 1 | 28 | 4% |
| SURMOUNT trial programme | 1 | 33 | 3% |
| Patent expiry and biosimilars | 1 | 30 | 3% |
| Triple agonist | 1 | 30 | 3% |
| Contraindications of incretin therapy | 1 | 28 | 4% |
| Syringe dead space | 1 | 31 | 3% |
| STEP trial programme | 1 | 35 | 3% |
| Tianjin Finder Chemical | 1 | 33 | 3% |
| Peptide stability table | 1 | 33 | 3% |
| FLOW trial | 1 | 31 | 3% |
Awards
Disclosure
This editor declares no financial or professional relationship with any organisation covered by PeptidePedia Wiki. Editors who do have such a relationship are required to disclose it here under Project:Conflict of interest.